Lycopene decision delayed
This article was originally published in The Tan Sheet
Executive Summary
FDA will not issue a decision before April 12 on a health claim stating lycopene is an "effective modifier of the risk of certain cancers," law firm Emord & Associates states Feb. 10. The agency was supposed to respond to the petition Dec. 24. Emord filed the petition on behalf of American Longevity in June 2003 (1"The Tan Sheet" June 9, 2003, p. 17)...